about
Targeting the Epidermal Growth Factor Receptor in Addition to Chemotherapy in Patients with Advanced Pancreatic Cancer: A Systematic Review and Meta-AnalysisGermline mutations in pancreatic cancer and potential new therapeutic options.Advances in Molecular Profiling and Categorisation of Pancreatic Adenocarcinoma and the Implications for Therapy.Complementary medicine use among cancer patients receiving radiotherapy and chemotherapy: methods, sources of information and the need for counselling.Sorafenib as first-line therapy in patients with advanced Child-Pugh B hepatocellular carcinoma-a meta-analysisIdentification of patients with pancreatic adenocarcinoma due to inheritable mutation: Challenges of daily clinical practiceThe importance of quality-of-life management in patients with advanced pancreatic ductal adenocarcinomaElderly patients diagnosed with hepatopancreatobiliary malignancies: A challenge beyond resectionIrreversible Electroporation in pancreatic ductal adenocarcinoma: Is there a role in conjunction with conventional treatment?
P50
Q33754779-DB5F0557-3A92-4DEC-BCD7-94ACF180C7DAQ42700671-D93F3BB0-9BE9-4CEA-B052-E5983EF33383Q47735303-FAEEF658-EF0A-4F41-9F0C-166A9280C7C7Q54776077-5A14AAFD-E3F7-4E4D-B905-97FBCBDAFA7CQ58102736-E8290193-3B3A-4092-AC7F-345D3D5B9476Q61795973-DAE40758-026A-4ACB-A3FD-C131509DFD68Q88309865-83711FAD-4B0F-48ED-9983-8D017DA82CFDQ89467209-58BBFF08-B427-4A6E-BC8E-0065D4246DFAQ91145797-F8CF402E-2EFF-4027-BCE3-8A51ADA2627B
P50
description
investigador
@es
researcher
@en
name
R Pihlak
@en
type
label
R Pihlak
@en
prefLabel
R Pihlak
@en
P31
P496
0000-0002-6055-334X